BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28591687)

  • 1. mTOR-mediated Na
    Yang Y; Luo Z; Hao Y; Ba W; Wang R; Wang W; Ding X; Li C
    Biomed Pharmacother; 2017 Aug; 92():744-749. PubMed ID: 28591687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.
    Dai L; Zhuang L; Zhang B; Wang F; Chen X; Xia C; Zhang B
    Int J Mol Sci; 2015 Dec; 16(12):28510-22. PubMed ID: 26633375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.
    Werzowa J; Koehrer S; Strommer S; Cejka D; Fuereder T; Zebedin E; Wacheck V
    J Invest Dermatol; 2011 Feb; 131(2):495-503. PubMed ID: 21048785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
    Campbell TM; Main MJ; Fitzgerald EM
    J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway.
    Shi J; Zhang W; He L; Kong F; Pan M; Guo J; Xu X; Guo J; Wang H; Wang Y
    Drug Des Devel Ther; 2019; 13():1023-1032. PubMed ID: 31114156
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer.
    Hernandez-Plata E; Ortiz CS; Marquina-Castillo B; Medina-Martinez I; Alfaro A; Berumen J; Rivera M; Gomora JC
    Int J Cancer; 2012 May; 130(9):2013-23. PubMed ID: 21630263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal administration of rapamycin inhibits the phosphorylation of DRG Nav1.8 and attenuates STZ-induced painful diabetic neuropathy in rats.
    He WY; Zhang B; Xiong QM; Yang CX; Zhao WC; He J; Zhou J; Wang HB
    Neurosci Lett; 2016 Apr; 619():21-8. PubMed ID: 26946108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR is activated in the majority of malignant melanomas.
    Karbowniczek M; Spittle CS; Morrison T; Wu H; Henske EP
    J Invest Dermatol; 2008 Apr; 128(4):980-7. PubMed ID: 17914450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional voltage-gated Na(+) channels in cultured human pulmonary artery smooth muscle cells.
    Platoshyn O; Remillard CV; Fantozzi I; Sison T; Yuan JX
    Pflugers Arch; 2005 Nov; 451(2):380-387. PubMed ID: 16052353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Inhibition of Wee1 Kinase Selectively Modulates the Voltage-Gated Na
    Dvorak NM; Tapia CM; Baumgartner TJ; Singh J; Laezza F; Singh AK
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A.
    Carrithers MD; Chatterjee G; Carrithers LM; Offoha R; Iheagwara U; Rahner C; Graham M; Waxman SG
    J Biol Chem; 2009 Mar; 284(12):8114-26. PubMed ID: 19136557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of motogenic signal in human melanoma cells].
    Kenessey I
    Magy Onkol; 2011 Mar; 55(1):55-8. PubMed ID: 21617791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Zhao G; Han X; Cheng W; Ni J; Zhang Y; Lin J; Song Z
    Oncol Rep; 2017 Apr; 37(4):2277-2285. PubMed ID: 28260058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
    Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
    Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
    Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
    Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
    Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.